Stuart Connolly - Articles and news items

Boehringer Ingelheim logo

New long-term data reinforce safety profile of Pradaxa® for stroke prevention in AF

Industry news, News / 17 June 2013 / Boehringer Ingelheim

New long-term data from the RELY-ABLE® study…

Boehringer Ingelheim logo

RELY-ABLE®: Unprecedented long-term data support safety profile and sustained efficacy of Pradaxa®

Industry news, News / 8 November 2012 / Boehringer Ingelheim

Pivotal data from the RELY-ABLE® study have provided additional data…

Boehringer Ingelheim logo
Boehringer Ingelheim logo

PRADAXA® (dabigatran etexilate) first drug in 50 years to gain approval for stroke prevention in atrial fibrillation in Europe

Industry news, News / 4 August 2011 / Ogilvy Healthworld UK Limited

Pradaxa®1 (dabigatran etexilate) approved…

Sanofi provides Multaq® Phase IIIb PALLAS trial update

Industry news, News / 7 July 2011 / Sanofi

Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial…

Pfizer logo

Apixaban statistically superior to aspirin in reducing the composite of stroke or systemic embolism

Industry news, News / 10 February 2011 / Pfizer

Bristol-Myers Squibb Company and Pfizer Inc. announce the publication of their AVERROES study of apixaban in The New England Journal of Medicine…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...